Gordon KB - Search Results

1

Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial.

Gordon KB, Papp KA, Hamilton TK, Walicke PA, Dummer W, Li N, Bresnahan BW, Menter A; Efalizumab Study Group. Gordon KB, et al. JAMA. 2003 Dec 17;290(23):3073-80. doi: 10.1001/jama.290.23.3073. JAMA. 2003. PMID: 14679270 Clinical Trial.

2

Evolution of biologic therapies for the treatment of psoriasis.

Gordon KB, McCormick TS. Gordon KB, et al. Skinmed. 2003 Sep-Oct;2(5):286-94. doi: 10.1111/j.1540-9740.2003.01869.x. Skinmed. 2003. PMID: 14673261 Review.

3

Treatment of psoriasis with alefacept: correlation of clinical improvement with reductions of memory T-cell counts.

Gordon KB, Vaishnaw AK, O'Gorman J, Haney J, Menter A; Alefacept Clinical Study Group. Gordon KB, et al. Arch Dermatol. 2003 Dec;139(12):1563-70. doi: 10.1001/archderm.139.12.1563. Arch Dermatol. 2003. PMID: 14676071 Clinical Trial.

4

Remittive effects of intramuscular alefacept in psoriasis.

Gordon KB, Langley RG. Gordon KB, et al. J Drugs Dermatol. 2003 Dec;2(6):624-8. J Drugs Dermatol. 2003. PMID: 14711140 Clinical Trial.

5

Adalimumab: efficacy and safety in psoriasis and rheumatoid arthritis.

Patel T, Gordon KB. Patel T, et al. Among authors: gordon kb. Dermatol Ther. 2004;17(5):427-31. doi: 10.1111/j.1396-0296.2004.04045.x. Dermatol Ther. 2004. PMID: 15379777 Review.

6

Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis.

Gottlieb AB, Gordon KB, Lebwohl MG, Caro I, Walicke PA, Li N, Leonardi CL; EFALIZUMAB STUDY GROUP. Gottlieb AB, et al. Among authors: gordon kb. J Drugs Dermatol. 2004 Nov-Dec;3(6):614-24. J Drugs Dermatol. 2004. PMID: 15624744 Clinical Trial.

7

Definitions of measures of effect duration for psoriasis treatments.

Gordon KB, Feldman SR, Koo JY, Menter A, Rolstad T, Krueger G. Gordon KB, et al. Arch Dermatol. 2005 Jan;141(1):82-4. doi: 10.1001/archderm.141.1.82. Arch Dermatol. 2005. PMID: 15655149 No abstract available.

8

The efficacy of alefacept in the treatment of chronic plaque psoriasis.

Gordon KB, Valentine J. Gordon KB, et al. J Cutan Med Surg. 2004 Dec;8 Suppl 2:3-9. doi: 10.1007/s10227-004-9502-3. J Cutan Med Surg. 2004. PMID: 15668749 Review.

9

Psoriasis treatment: current and emerging directed therapies.

Winterfield LS, Menter A, Gordon K, Gottlieb A. Winterfield LS, et al. Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii87-90; discussion ii91-2. doi: 10.1136/ard.2004.032276. Ann Rheum Dis. 2005. PMID: 15708946 Free PMC article. Review.

10

Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial.

Leonardi CL, Papp KA, Gordon KB, Menter A, Feldman SR, Caro I, Walicke PA, Compton PG, Gottlieb AB; Efalizumab Study Group. Leonardi CL, et al. Among authors: gordon kb. J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):425-33. doi: 10.1016/j.jaad.2004.09.029. J Am Acad Dermatol. 2005. PMID: 15761420 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters